Efficacy of low-dose valganciclovir in CMV R+ lung transplant recipients: a retrospective comparative analysis.

Multidiscip Respir Med · 2021 · PMC7868948 · PMID 33569173

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Overall, this analysis showed a trend toward benefit with the high-dose valganciclovir regimen.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.